M. Hassan Alkazemi MD MS Profile
M. Hassan Alkazemi MD MS

@AlkazemiMD

Followers
204
Following
573
Media
4
Statuses
24

Urologic Oncology Fellow @UrologyMSK | via @WashU_Uro @DukeMedSchool & @Yale |

New York, NY
Joined April 2022
Don't wanna be here? Send us removal request.
@AlkazemiMD
M. Hassan Alkazemi MD MS
16 days
RT @MaxKates: “I know there’s a lot of people out there going through what I am going through and dealing with what I am dealing with and l….
0
5
0
@AlkazemiMD
M. Hassan Alkazemi MD MS
16 days
RT @UrologyMSK: 🥇🥇🥇We are thrilled to announce our number one ranking in Urology for the third straight year! Truly a testament to our amaz….
Tweet card summary image
health.usnews.com
Learn which hospitals were ranked best by US News & World Report for urology. Scores factor in patient safety, nurse staffing and more.
0
10
0
@AlkazemiMD
M. Hassan Alkazemi MD MS
2 months
RT @UrologyMSK: Congratulations to @arihakimi who was chosen unanimously by the class of 2025 Urologic Oncology Fellows as Teacher of the….
0
9
0
@AlkazemiMD
M. Hassan Alkazemi MD MS
2 months
RT @EricKleinMD: What does it mean to be a surgical oncologist? I never fully understood till I retired. https:/….
0
3
0
@AlkazemiMD
M. Hassan Alkazemi MD MS
2 months
RT @TouijerKarim: Great distinction from @EUplatinum for our trial on pelvic lymph node dissection in #prostatecancer . Gratitude to the….
0
11
0
@AlkazemiMD
M. Hassan Alkazemi MD MS
2 months
RT @WesleyYipMD: Very excited to see our #bladdercancer and #UTUC review now published in @CACancerJournal, written with the collaborative….
0
12
0
@AlkazemiMD
M. Hassan Alkazemi MD MS
3 months
Humbled and honored to be among this year’s @ConquerCancerFd YIA grant recipients. Indebted to my mentors — Dr. @eugene_pietzak , Dr. @IyerGopa , and the team at @UrologyMSK @MSKCancerCenter — for their unwavering guidance and support. Excited for the future #ASCO25
Tweet media one
Tweet media two
@ConquerCancerFd
Conquer Cancer, the ASCO Foundation
3 months
Congratulations to this year’s class of Conquer Cancer grant and award recipients! Are you one of them? Tell us in the comments! We can't wait to celebrate with you at #ASCO25. Full list of recipients: @ASCO
Tweet media one
4
2
27
@AlkazemiMD
M. Hassan Alkazemi MD MS
3 months
RT @UrologyMSK: Our rockstar fellows are continuously making us so proud! A special shout out to @YashKhandwalaMD and @AlkazemiMD for their….
0
2
0
@AlkazemiMD
M. Hassan Alkazemi MD MS
3 months
RT @_backtableUro: Dr. Clinton and Dr. Pietzak discussed the management of BCG-refractory NMIBC and highlighted recent BCG and gemcitabine….
0
5
0
@AlkazemiMD
M. Hassan Alkazemi MD MS
3 months
RT @bbmdmsk: Terrific day #1 of our open surgical skills training program for our @UrologyMSK research fellows about to start their clinica….
0
11
0
@AlkazemiMD
M. Hassan Alkazemi MD MS
4 months
RT @UrologyMSK: Amazing Whitmore Visiting Professor visit from ⭐️ alum @uroegg! Spent time with our fellows and faculty and gave an outstan….
0
4
0
@AlkazemiMD
M. Hassan Alkazemi MD MS
5 months
Had a great time learning the continuous re-evaluation/staccato/“tap-tap” technique for complex TURBTs with @bbmdmsk @DrJohnSfakianos @JoshMeeks at the Olympus-sponsored course @Olympus_Corp this past weekend. Highly recommend urologists apply in the future—participants ranged
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
2
19
@AlkazemiMD
M. Hassan Alkazemi MD MS
5 months
RT @bbmdmsk: Book another successful hands-on TURBT course. Life like models, incredible support by @Olympus_Corp . Thank you to my collea….
0
4
0
@AlkazemiMD
M. Hassan Alkazemi MD MS
5 months
Excited to share our latest work on micropapillary bladder cancer presented at #ASCOGU25! We conducted a retrospective survival analysis to better understand outcomes in this rare variant - focusing on percentage of MP disease in the cystectomy sample. Watch the full discussion.
@BladderCancerUS
Bladder Cancer Advocacy Network
5 months
Video in @Urotoday: Micropapillary Histology in Bladder Cancer: A Retrospective Survival Analysis - with @Urodocash @alkazemimd & @h_alahmadie. Click here to watch the video:
0
1
15
@AlkazemiMD
M. Hassan Alkazemi MD MS
5 months
RT @bbmdmsk: Another useful strategy for pts with NMIBC previously exposed to BCG. Great work by @eugene_pietzak and the @UrologyMSK team.@….
0
8
0
@AlkazemiMD
M. Hassan Alkazemi MD MS
6 months
RT @urotoday: Phase II trial explores gemcitabine + BCG for BCG-exposed #BladderCancer. @eugene_pietzak @MSKCancerCenter & @WaldoGMed @WCMU….
0
5
0
@AlkazemiMD
M. Hassan Alkazemi MD MS
6 months
RT @bavilima: @ASCO #GU25 Poster Session.#BladderCancer @UrologyMSK @UroMuneeb @eugene_pietzak . E6- The impact of micropapillary histology….
0
8
0
@AlkazemiMD
M. Hassan Alkazemi MD MS
9 months
0
0
1
@AlkazemiMD
M. Hassan Alkazemi MD MS
9 months
I recently attended the MSKCC course on the “2024 Update on the Multimodality Management of Bladder and Kidney Cancer,” and it was a phenomenal experience. The event was impeccably organized, with a perfect blend of panel discussions, case presentations, and updates on the latest
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
2
20